175 related articles for article (PubMed ID: 30705373)
1. Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers.
Ghanbari A; Le Gresley A; Naughton D; Kuhnert N; Sirbu D; Ashrafi GH
Sci Rep; 2019 Jan; 9(1):1013. PubMed ID: 30705373
[TBL] [Abstract][Full Text] [Related]
2.
Cakir MO; Bilge U; Naughton D; Ashrafi GH
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686451
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Effect of
Cakir MO; Bilge U; Ghanbari A; Ashrafi GH
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139849
[TBL] [Abstract][Full Text] [Related]
4. The aqueous extract of Ficus religiosa induces cell cycle arrest in human cervical cancer cell lines SiHa (HPV-16 Positive) and apoptosis in HeLa (HPV-18 positive).
Choudhari AS; Suryavanshi SA; Kaul-Ghanekar R
PLoS One; 2013; 8(7):e70127. PubMed ID: 23922932
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Indian Fig Fruit Extract on Human Papilloma Virus containing Cervical Cancer Cells (HeLa) by Decreasing the HPV18 L1 Gene Load.
Grace VMB; B L; Wilson DD
Asian Pac J Cancer Prev; 2021 Mar; 22(3):785-791. PubMed ID: 33773542
[TBL] [Abstract][Full Text] [Related]
6. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines.
Tezcan G; Tunca B; Bekar A; Yalcin M; Sahin S; Budak F; Cecener G; Egeli U; Demir C; Guvenc G; Yilmaz G; Erkan LG; Malyer H; Taskapilioglu MO; Evrensel T; Bilir A
Cell Mol Neurobiol; 2015 Mar; 35(2):175-87. PubMed ID: 25212824
[TBL] [Abstract][Full Text] [Related]
7. Fig latex (Ficus carica L. cultivar Dottato) in combination with UV irradiation decreases the viability of A375 melanoma cells in vitro.
Menichini G; Alfano C; Provenzano E; Marrelli M; Statti GA; Somma F; Menichini F; Conforti F
Anticancer Agents Med Chem; 2012 Oct; 12(8):959-65. PubMed ID: 22339064
[TBL] [Abstract][Full Text] [Related]
8. Antitumoral activity of Ficus carica L. on colorectal cancer cell lines.
Soltana H; Pinon A; Limami Y; Zaid Y; Khalki L; Zaid N; Salah D; Sabitaliyevich UY; Simon A; Liagre B; Hammami M
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):6-11. PubMed ID: 31472041
[TBL] [Abstract][Full Text] [Related]
9. Targeted juglone blocks the invasion and metastasis of HPV-positive cervical cancer cells.
Zhao X; Zhu W; Zhang R; Zhang M; Zhao J; Hou J; Zhang W
J Pharmacol Sci; 2019 Jul; 140(3):211-217. PubMed ID: 31445828
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
13. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
14. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Belcastro M; Miller MR; Flynn DC; Soisson AP
Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
16. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
17. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
Wang H; Gao P; Zheng J
Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
